NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,114 filers reported holding NOVARTIS A G in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,075,903 | -5.7% | 187,275 | -6.6% | 0.08% | 0.0% |
| Q2 2023 | $20,232,649 | +8.6% | 200,499 | -0.9% | 0.08% | +5.6% |
| Q1 2023 | $18,623,211 | -32.9% | 202,422 | -36.7% | 0.07% | +28.6% |
| Q4 2022 | $27,751,914 | +76.4% | 319,925 | +54.5% | 0.06% | -20.0% |
| Q3 2022 | $15,736,000 | +11.1% | 207,027 | +2.2% | 0.07% | +4.5% |
| Q2 2022 | $14,170,000 | -4.8% | 202,614 | +19.5% | 0.07% | +1.5% |
| Q1 2022 | $14,883,000 | +9.9% | 169,616 | +9.5% | 0.07% | +15.8% |
| Q4 2021 | $13,546,000 | -20.9% | 154,867 | -26.1% | 0.06% | -26.0% |
| Q3 2021 | $17,128,000 | -8.4% | 209,443 | +2.2% | 0.08% | -6.1% |
| Q2 2021 | $18,698,000 | +2.4% | 204,941 | -4.0% | 0.08% | +3.8% |
| Q1 2021 | $18,251,000 | -16.3% | 213,511 | -7.5% | 0.08% | -17.7% |
| Q4 2020 | $21,808,000 | +4.9% | 230,940 | -3.4% | 0.10% | -5.9% |
| Q3 2020 | $20,798,000 | -0.5% | 239,158 | -0.1% | 0.10% | -8.9% |
| Q2 2020 | $20,904,000 | +7.8% | 239,332 | +1.8% | 0.11% | -2.6% |
| Q1 2020 | $19,384,000 | -10.8% | 235,085 | +2.4% | 0.12% | +12.7% |
| Q4 2019 | $21,732,000 | +8.6% | 229,501 | -0.3% | 0.10% | +2.0% |
| Q3 2019 | $20,012,000 | -6.0% | 230,287 | -1.2% | 0.10% | -9.9% |
| Q2 2019 | $21,288,000 | -6.7% | 233,140 | -1.7% | 0.11% | -6.7% |
| Q1 2019 | $22,813,000 | +12.2% | 237,288 | +0.1% | 0.12% | +1.7% |
| Q4 2018 | $20,331,000 | -1.7% | 236,938 | -1.3% | 0.12% | +13.6% |
| Q3 2018 | $20,678,000 | +13.3% | 239,993 | -0.7% | 0.10% | +5.1% |
| Q2 2018 | $18,250,000 | -7.7% | 241,596 | -1.2% | 0.10% | -7.5% |
| Q1 2018 | $19,762,000 | -8.4% | 244,411 | -4.8% | 0.11% | -6.2% |
| Q4 2017 | $21,567,000 | -3.9% | 256,860 | -1.7% | 0.11% | -7.4% |
| Q3 2017 | $22,431,000 | +5.3% | 261,270 | +2.4% | 0.12% | -3.2% |
| Q2 2017 | $21,303,000 | +11.6% | 255,223 | -0.7% | 0.13% | +9.6% |
| Q1 2017 | $19,086,000 | +3.7% | 256,981 | +1.7% | 0.12% | 0.0% |
| Q4 2016 | $18,404,000 | -9.5% | 252,662 | -1.9% | 0.12% | -11.5% |
| Q3 2016 | $20,338,000 | -2.9% | 257,578 | +1.5% | 0.13% | -7.8% |
| Q2 2016 | $20,947,000 | +2.0% | 253,868 | -10.5% | 0.14% | +1.4% |
| Q1 2016 | $20,543,000 | -20.0% | 283,686 | -4.9% | 0.14% | -18.2% |
| Q4 2015 | $25,666,000 | -6.4% | 298,307 | -0.1% | 0.17% | -9.1% |
| Q3 2015 | $27,417,000 | -7.1% | 298,561 | -0.6% | 0.19% | +5.1% |
| Q2 2015 | $29,524,000 | -1.6% | 300,221 | -1.3% | 0.18% | -4.8% |
| Q1 2015 | $29,990,000 | +2.8% | 304,128 | -4.1% | 0.19% | +2.2% |
| Q4 2014 | $29,180,000 | -1.4% | 317,098 | +0.2% | 0.18% | -3.7% |
| Q3 2014 | $29,591,000 | +922.1% | 316,500 | +889.6% | 0.19% | +57.0% |
| Q2 2014 | $2,895,000 | +6.7% | 31,982 | +0.2% | 0.12% | +7.1% |
| Q1 2014 | $2,713,000 | +2.6% | 31,904 | -3.0% | 0.11% | +1.8% |
| Q4 2013 | $2,644,000 | +3.7% | 32,889 | -1.0% | 0.11% | -9.0% |
| Q3 2013 | $2,549,000 | +8.1% | 33,220 | -0.4% | 0.12% | +7.0% |
| Q2 2013 | $2,359,000 | – | 33,353 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |